Oliver Bell

Oliver Bell

Auto-generated profile, based on publicly available information

Oliver Bell

Department of Cancer Biology, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Cell
Verified
Journal Article
Closed access
NHNathaniel A. Hathaway
Nathaniel A. Hathaway
OBOliver Bell
Oliver Bell
HHH. Courtney Hodges
H. Courtney Hodges
EMErik L. Miller
Erik L. Miller
DNDana S. Neel
Dana S. Neel
GCGerald R. Crabtree
Gerald R. Crabtree

12 July 2011 in Nature Reviews Genetics
Verified
Journal Article
Closed access
OBOliver Bell
Oliver Bell
VTVijay K. Tiwari
Vijay K. Tiwari
NTNicolas H. Thomä
Nicolas H. Thomä
DSDirk Schübeler
Dirk Schübeler

9 December 2015 in Nature
Verified
Journal Article
Open access
PDF file
SCSihem Cheloufi
Sihem Cheloufi
UEUlrich Elling
Ulrich Elling
BHBarbara Hopfgartner
Barbara Hopfgartner
YJYoungsook L. Jung
Youngsook L. Jung
JMJernej Murn
Jernej Murn
KHKonrad Hochedlinger
Konrad Hochedlinger
Cellular differentiation involves profound remodelling of chromatic landscapes, yet the mechanisms by which somatic cell identity is subsequently maintained remain incompletely understood. To further elucidate regulatory pathways that safeguard the somatic state, we performed two comprehensive RNA interference (RNAi) screens targeting chromatin factors during transcription-factor-mediated reprogramming of mouse fibroblasts to induced pluripotent stem cells (iPS cells). Subunits of the chromatin assembly factor-1 (CAF-1) complex, including Chaf1a and Chaf1b, emerged as the most prominent hits from both screens, followed by modulators of lysine sumoylation and heterochromatin maintenance. Optimal modulation of both CAF-1 and transcription factor levels increased reprogramming efficiency by several orders of magnitude and facilitated iPS cell formation in as little as 4 days. Mechanistically, CAF-1 suppression led to a more accessible chromatin structure at enhancer elements early during reprogramming. These changes were accompanied by a decrease in somatic heterochromatin domains, increased binding of Sox2 to pluripotency-specific targets and activation of associated genes. Notably, suppression of CAF-1 also enhanced the direct conversion of B cells into macrophages and fibroblasts into neurons. Together, our findings reveal the histone chaperone CAF-1 to be a novel regulator of somatic cell identity during transcription-factor-induced cell-fate transitions and provide a potential strategy to modulate cellular plasticity in a regenerative setting.

1 October 2005 in Blood
Verified
Journal Article
Closed access
BGBruno Galy
Bruno Galy
DFDunja Ferring
Dunja Ferring
BMBelen Minana
Belen Minana
OBOliver Bell
Oliver Bell
HJHeinz G. Janser
Heinz G. Janser
MHMatthias W. Hentze
Matthias W. Hentze
Iron regulatory protein 2 (IRP2)-deficient mice have been reported to suffer from late-onset neurodegeneration by an unknown mechanism. We report that young adult Irp2-/- mice display signs of iron mismanagement within the central iron recycling pathway in the mammalian body, the liver-bone marrow-spleen axis, with altered body iron distribution and compromised hematopoiesis. In comparison with wild-type littermates, Irp2-/- mice are mildly microcytic with reduced serum hemoglobin levels and hematocrit. Serum iron and transferrin saturation are unchanged, and hence microcytosis is not due to an overt decrease in systemic iron availability. The liver and duodenum are iron loaded, while the spleen is iron deficient, associated with a reduced expression of the iron exporter ferroportin. A reduction in transferrin receptor 1 (TfR1) mRNA levels in the bone marrow of Irp2-/- mice can plausibly explain the microcytosis by an intrinsic defect in erythropoiesis due to a failure to adequately protect TfR1 mRNA against degradation. This study links a classic regulator of cellular iron metabolism to systemic iron homeostasis and erythropoietic TfR1 expression. Furthermore, this work uncovers aspects of mammalian iron metabolism that can or cannot be compensated for by the expression of IRP1. (Blood. 2005;106: 2580-2589)

1 August 2005 in Genes & Development
Verified
Journal Article
Open access
PDF file
CWChristiane Wirbelauer
Christiane Wirbelauer
OBOliver Bell
Oliver Bell
DSDirk Schübeler
Dirk Schübeler
Deposition of variant histones provides a mechanism to reset and to potentially specify chromatin states. We determined the distribution of H3 and its variant H3.3 relative to chromatin structure and elongating polymerase. H3.3 is enriched throughout active genes similar to polymerase, yet its distribution is very distinct from that of several euchromatic histone modifications, which are highly biased toward the 5′ part of active genes. Upon gene induction we observe displacement of both H3 and H3.3 followed by selective deposition of H3.3. These results support a model in which H3.3 deposition compensates for transcription-coupled nucleosomal displacement yet does not predetermine tail modifications.

15 November 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
OBOliver Bell
Oliver Bell
CWChristiane Wirbelauer
Christiane Wirbelauer
MHMarc Hild
Marc Hild
ASAnnette Nd Scharf
Annette Nd Scharf
MSMichaela Schwaiger
Michaela Schwaiger
DSDirk Schübeler
Dirk Schübeler
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.